| A basic insight into aptamer-drug conjugates (ApDCs) W Xuan, Y Peng, Z Deng, T Peng, H Kuai, Y Li, J He, C Jin, Y Liu, R Wang, ... Biomaterials 182, 216-226, 2018 | 99 | 2018 |
| Aptamer-peptide conjugates as targeted chemosensitizers for breast cancer treatment Y Tan, Y Li, YX Qu, Y Su, Y Peng, Z Zhao, T Fu, XQ Wang, W Tan ACS applied materials & interfaces 13 (8), 9436-9444, 2020 | 38 | 2020 |
| Functional nucleic acids for cancer theranostics T Peng, Z Deng, J He, Y Li, Y Tan, Y Peng, XQ Wang, W Tan Coordination Chemistry Reviews 403, 213080, 2020 | 37 | 2020 |
| A Dual‐Targeting Circular Aptamer Strategy Enables the Recognition of Different Leukemia Cells with Enhanced Binding Ability L Ai, T Peng, Y Li, H Kuai, Y Sima, M Su, D Wang, Q Yang, XQ Wang, ... Angewandte Chemie International Edition 61 (33), e202109500, 2022 | 18 | 2022 |
| A new paradigm for artesunate anticancer function: Considerably enhancing the cytotoxicity via conjugating artesunate with aptamer Y Li, Y Peng, Y Tan, W Xuan, T Fu, XQ Wang, W Tan Signal Transduction and Targeted Therapy 6 (1), 327, 2021 | 15 | 2021 |
| Molecularly engineered aptamers targeting tumor tissue and cancer cells for efficient in vivo recognition and enrichment X Wang, XJ Zhang, Y Li, GR Zhang, J Li, XQ Wang, W Tan CCS Chemistry 4 (8), 2581-2587, 2022 | 14 | 2022 |
| Aptamer enables consistent maytansine delivery through maintaining receptor homeostasis for HER2 targeted cancer therapy Y Tan, Y Peng, L Ai, Y Li, Y Qu, D Wang, Y Su, T Deng, T Fu, Z Zhao, ... Bioconjugate Chemistry 31 (7), 1766-1774, 2020 | 12 | 2020 |
| Aptamer Inhibits Tumor Growth by Leveraging Cellular Proteasomal Degradation System to Degrade c‐Met in Mice K Chen, J Cai, S Wang, Y Li, C Yang, T Fu, Z Zhao, X Zhang, W Tan Angewandte Chemie International Edition 62 (2), e202208451, 2023 | 11 | 2023 |
| Bispecific circular aptamer for enhanced targeted drug deliver L Ai, T Peng, Y Li, J He, X Wang, Z Zhao, W Tan 第十一届全国化学生物学学术会议论文摘要 (第三卷), 2019 | | 2019 |
